Ulrich Mrowietz, MD University Medical Center Schleswig-Holstein Kiel, Germany
Ulrich Mrowietz is a Professor of Dermatology and the founder of the Psoriasis Center in the Department of Dermatology at the University Medical Center Schleswig-Holstein, Campus Kiel, Germany. His main research areas in psoriasis include management strategies, drug development, and basic research. The Psoriasis Center provides a large clinical trial unit and is part of the Comprehensive Center for Inflammation Medicine at the Kiel Campus. Professor Mrowietz is the author or co-author of more than 375 peer-reviewed publications listed in the Medline database and numerous other publications in the field. His h-Index is 65. In addition, he is the author of chapters in multiple psoriasis textbooks, including Braun-Falco’s Dermatology and Venerology. From 2004 to 2019, Professor Mrowietz was Editor-in-Chief of Archives of Dermatological Research. He is a former member of the Executive Board of the German Dermatological Society, a councilor of the International Psoriasis Council, a member of the scientific advisory board of the German Psoriasis Association, a member of the Clusters of Excellence “Inflammation at Interfaces” and “Precision Medicine in Chronic Inflammation,” and of numerous dermatological societies. Professor Mrowietz was President of the 6th World Psoriasis and Psoriatic Arthritis Conference in June/July 2021 in Stockholm, Sweden.
Last Updated: Mar 08, 2022
MAY 11, 2022
Carlo Pincelli, MD, PhD University of Modena & Reggio Emiliana Modena, Italy
Prof. Pincelli earned his MD and the Specialization in Dermatology from the University of Modena and Reggio Emilia. He was trained at research institutions internationally (St. John's Hospital for Diseases of the Skin in London, Department of Dermatology, the University of California in San Francisco, and School of Medicine at Boston University, Boston). For 30 years, he has held the position of Professor of Dermatology and Director of Research at the DermoLab of the University of Modena and Reggio Emilia, where he is currently a Consultant and Senior Professor. Prof Pincelli is an Honorary Member of the European Society for Dermatological Research (ESDR), where he served as President in 2007. He received the Pro-Meritis Award from the European Dermatology Forum for his outstanding contribution to the advancement of Dermatology in Europe. He owns five international patents and founded two startups devoted to researching and developing new therapies in dermatology.
Last Updated: Apr 09, 2022
April 12, 2022
now available COVID-19 Psoriasis Resource Center Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve explore now
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Latest news Dermavant Announces FDA Approval for VTAMA® (Tapinarof) CreamMay 26, 2022Dermavant announced the FDA approval for VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults. This is the first topical novel chemical entity launched for psoriasis in the U.S. in 25 years. Bristol Myers Squibb (BMS) Announces New Two-Year Deucravacitinib DataMay 16, 2022Bristol Myers Squibb (BMS) announced new two-year data that reinforces the durable efficacy and consistent safety profile of Deucravacitinib when used to treat moderate to severe plaque psoriasis. Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 PandemicMay 11, 2022IPC Councilor, Ulrich Mrowietz, MD, shares his expert opinion on Cook et al (Br J Dermatol 2022 (online first)) report on the interruption of psoriasis care during the COVID-19 pandemic and vaccine hesitancy in patients with psoriasis. New Corporate MemberMay 03, 2022IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member! More News